| J9271 | Injection, pembrolizumab, 1 mg | 11,600 | $40 | $498.8K |
| J0897 | Injection, denosumab, 1 mg | 3,000 | $20 | $57K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 590 | $90 | $53.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 280 | $140 | $37.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,380 | $1 | $34.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $100 | $28.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $130 | $15.9K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 180 | $80 | $13.7K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 120 | $100 | $11.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $150 | $9.1K |